<DOC>
	<DOC>NCT02006342</DOC>
	<brief_summary>To determine if co-administration of subcutaneous (SQ)Insulin glargine in combination with intravenous (IV) insulin decreases the time to resolution of ketoacidosis and requirement for ICU admission compared to IV insulin with delayed administration of SQ glargine for the treatment of DKA.</brief_summary>
	<brief_title>Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Ketosis</mesh_term>
	<mesh_term>Diabetic Ketoacidosis</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Age &gt;18 years Blood Glucose &gt;200 pH &lt; 7.3 Bicarbonate &lt; 18 Ketonemia or Ketonuria Anion Gap &gt; or = 16 Age &lt; 18 years Pregnant ESRD Prisoners Patients in shock or requiring emergency surgery Those unwilling to consent for the trial Allergic to Insulin Glargine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Diabetic Ketoacidosis</keyword>
	<keyword>Insulin Glargine</keyword>
	<keyword>Anion gap</keyword>
	<keyword>Metabolic acidosis</keyword>
</DOC>